which compound to select in lead optimization prospectively validated proteochemometric models guide preclinical development在铅化合物选择优化前瞻性验证proteochemometric模型指导临床前开发.pdfVIP

  • 14
  • 0
  • 约10.99万字
  • 约 13页
  • 2017-09-12 发布于上海
  • 举报

which compound to select in lead optimization prospectively validated proteochemometric models guide preclinical development在铅化合物选择优化前瞻性验证proteochemometric模型指导临床前开发.pdf

which compound to select in lead optimization prospectively validated proteochemometric models guide preclinical development在铅化合物选择优化前瞻性验证proteochemometric模型指导临床前开发

Which Compound to Select in Lead Optimization? Prospectively Validated Proteochemometric Models Guide Preclinical Development 1 ¨ 2 2 2 2 Gerard J. P. van Westen , Jorg K. Wegner , Peggy Geluykens , Leen Kwanten , Inge Vereycken , Anik 2 1 1,2 1,3 Peeters , Adriaan P. IJzerman , Herman W. T. van Vlijmen

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档